Cochrane Summaries

Trusted evidence. Informed decisions. Better health.

No evidence to support or refute glucocorticosteroids for viral hepatitis C

Brok J, Mellerup MT, Krogsgaard K, Gluud C
Published Online: 
21 January 2009

Acute infection with viral hepatitis C manifests most commonly no symptoms, but frequently results in chronic infection. Chronic hepatitis C is in most cases benign, but may progress to severe illness and liver-related death. This review found no significant effect of glucocorticosteroids on chronic hepatitis, but the amount of data is sparse. Accordingly there is insufficient evidence to neither confirm nor exclude beneficial and harmful effects of glucocorticosteroids for hepatitis C. Further, the evidence is unclear as to whether glucocorticosteroids treatment can be safely administered for other diseases in patients with concomitant hepatitis C. The authors were unable to identify randomised clinical trials on glucocorticosteroids for acute hepatitis C.

This record should be cited as: 
Brok J, Mellerup MT, Krogsgaard K, Gluud C. Glucocorticosteroids for viral hepatitis C. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002904. DOI: 10.1002/14651858.CD002904.pub2
Assessed as up to date: 
8 December 2003